The Hindu Business Line : Aurobindo drug gets US FDA nod

Aurobindo Pharma Ltd has announced that the company has got the US Food and Drug Administration (US FDA) approval for Cefprozil tablets USP 250 mg & 500 mg.

Cefprozil is a second generation cephalosporin antibiotic. It is the generic version of the brand "Cefzil" manufactured and sold by Bristol-Myers Squibb Company Pharmaceutical Research Institute. According to an Aurobindo Pharma press release, Cefprozil is mostly used to treat upper, lower respiratory tract infections and skin infections. It enjoys a market of around $80 million in the US.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
`IOC losing Rs 2,500 cr every month'

50% rise in L&T fourth quarter net profit

HPCL Q4 net drops 73% at Rs 549.5 crore

Nagarjuna Construction Q4 net rises 40%

BMW to source components from India

Ranbaxy allowed to launch generic Lipitor

Scotland still lukewarm to Mallya

Strides enters fermentation biz; buys Italian company's unit

DS Constructions set to buy Globeleq unit

Aurobindo drug gets US FDA nod

Tata Steel signs MoU with Vietnam company

Elder Pharma ties up with Cymbiotics

`Scope for more joint ventures with Australia'

Hind Shipyard revamp for GoM

Eli Lilly working on diabetes injectible drug